Invesaro

Stocks ALURD Financial statements

Financial statements

ALLURION TECHNOLOGIES, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data ALLURION TECHNOLOGIES, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2023FY2023FY2024FY2025
Revenue64.253.532.115.2
Cost of revenue13.51210.65.66
Gross profit50.741.521.59.57
Research and development1727.717.47.57
Selling and marketing50.446.925.910.8
General and administrative15.44628.421.4
Operating expenses82.712171.739.7
Operating income-32-79.1-50.2-30.2
Interest expense4.4310.62.260
Other non-operating income-5.59-3.4843.71.48
Pre-tax income-37.6-82.6-6.48-28.7
Income tax0.140.260.720.07
Net income-37.7-82.8-7.2-28.8
EBITDA-31.1-78.3-49.2-29.2
EPS, basic-37.75-59.38-3.20-3.81
EPS, diluted-37.75-59.38-3.20-3.81
Shares, basic (weighted)1.081.422.257.54
Shares, diluted (weighted)1.081.422.257.54

Balance sheet

FY2023FY2023FY2024FY2025
Cash and equivalents7.693815.45.41
Receivables29.318.27.133.95
Inventory3.876.173.42.67
Other current assets2.492.411.240.76
Total current assets43.464.827.212.8
Property, plant and equipment2.383.382.471.37
Lease right-of-use assets2.93.012.080.95
Other non-current assets2.710.511.110.66
Total assets51.471.732.815.8
Accounts payable5.8110.46.573.57
Short-term debt53.438.635.7
Total current liabilities75.965.418.938.4
Long-term debt3.135.70
Lease liabilities2.162.311.340.57
Other non-current liabilities2.558.320.020.39
Total liabilities83.714311193
Total debt56.538.671.40
Paid-in capital99.9143153169
Retained earnings-132-215-222-251
Other comprehensive income0.7-8.375.14
Shareholders' equity-32.3-71.3-78-77.2
Total equity-32.3-71.3-78-77.2
Total liabilities and equity51.471.732.815.8
Shares outstanding1.081.912.7112.3

Cash flow statement

FY2023FY2023FY2024FY2025
Net income-37.7-82.8-7.2-28.8
Depreciation and amortization0.90.7510.98
Stock-based compensation0.448.363.063.15
Deferred income tax-0.20.25
Change in receivables-22.8-1.328.980.84
Change in inventory-1.15-3.710.54-0.49
Change in payables3.324.66-3.92-3.14
Cash from operations-47-64-42.3-28.9
Capital expenditures-1.55-1.61-0.61
Cash from investing-1.55-1.61-0.61
Cash from financing30.59620.219
Net change in cash-1830.4-22.7-9.98
Free cash flow-48.5-65.6-42.9
Interest paid3.488.042.67

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2026; growth uses fiscal years. Valuation uses the share price of $1.75 on August 26, 2026.

Profitability

MetricValueHow it is calculated
Gross margin52.7%Gross profit / revenue.
Operating margin-211.2%Operating income / revenue.
EBITDA margin-203.7%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-264.7%Pre-tax income / revenue.
Net margin-264.7%Net income / revenue.
Operating cash flow margin-180.2%Cash from operations / revenue.
Return on assets (ROA)-238.3%Net income / average total assets.
R&D / revenue46.5%Research and development expense / revenue.
Stock-based pay / revenue22.9%Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue7.5%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-52.6%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-38.1%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y-55.5%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-42.6%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y-51.9%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-32.5%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y235.7%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y91.4%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.30xCurrent assets / current liabilities.
Quick ratio0.23x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.14x(Cash + short-term investments) / current liabilities.
Debt / assets0.0%Total debt / total assets.
Liabilities / assets656.7%Total liabilities / total assets.
Net debt-$5.1MTotal debt - cash - short-term investments. Negative means more cash than debt.
Working capital-$26.0MCurrent assets - current liabilities.
Tangible book value-$77.9MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.90xRevenue / average total assets.
Fixed asset turnover10.3xRevenue / average property, plant and equipment.
Inventory turnover2.89xCost of revenue / average inventory.
Days inventory126 days365 x average inventory / cost of revenue.
Receivables turnover3.63xRevenue / average receivables.
Days sales outstanding101 days365 x average receivables / revenue.
Days payables188 days365 x average accounts payable / cost of revenue.
Cash conversion cycle39 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted-$2.50Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$0.94Revenue / diluted weighted shares.
Operating cash flow per share-$1.70Cash from operations / diluted weighted shares.
Book value per share-$5.20Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$5.20Tangible book value / shares outstanding.
Cash per share$0.34(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$26.3MShare price x shares outstanding.
Enterprise value$21.2MMarket cap + total debt - cash - short-term investments.
P/S2.08xMarket cap / revenue.
EV/Sales1.68xEnterprise value / revenue.
Earnings yield-127.0%Net income / market cap (the inverse of P/E).
What was ALLURION TECHNOLOGIES, INC.'s revenue in fiscal 2025?

ALLURION TECHNOLOGIES, INC. reported revenue of $15.2M for fiscal 2025, 52.6% lower than the year before.

Was ALLURION TECHNOLOGIES, INC. profitable in fiscal 2025?

No. It reported a net loss of $28.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ALLURION TECHNOLOGIES, INC.